Nkarta Announces June 2021 Investor Conference Schedule

Rhea-AI Summary

Nkarta, Inc. (Nasdaq: NKTX) announced its participation in the Jefferies Virtual Healthcare Conference on June 2, 2021, at 3:30 p.m. ET. The company focuses on developing engineered natural killer (NK) cell therapies for cancer treatment. A live webcast of the presentation will be available on the company’s website, with a replay accessible for four weeks. Nkarta aims to enhance tumor targeting through its proprietary technologies and efficient manufacturing processes, advancing its pipeline of allogeneic NK cell therapies.

Positive

• Participation in Jefferies Virtual Healthcare Conference showcases commitment to investor engagement.
• Focus on engineered NK cell therapies indicates strong potential for innovation in cancer treatment.

Negative

• None.

SOUTH SAN FRANCISCO, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at this upcoming investor conference:

Jefferies Virtual Healthcare Conference
June 2, 2021
Fireside chat presentation: 3:30 p.m. ET

The live webcast of the presentation will be available on the Investors section of Nkarta’s website, www.nkartatx.com. A replay of the webcast will be archived on the website for approximately four weeks.

About Nkarta
Nkarta is a clinical-stage biotechnology company advancing the development of allogeneic, off the shelf natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, which are engineered to enhance tumor targeting and improve persistence for sustained activity in the body. For more information, please visit www.nkartatx.com.

Nkarta Media/Investor Contact:
Greg Mann
Nkarta, Inc.
gmann@nkartatx.com

 

FAQ

When is Nkarta's presentation at the Jefferies Virtual Healthcare Conference?

Nkarta's presentation is scheduled for June 2, 2021, at 3:30 p.m. ET.

What is the focus of Nkarta, Inc.?

Nkarta is focused on developing engineered natural killer (NK) cell therapies for cancer treatment.

Where can I watch the Nkarta conference presentation?

The conference presentation can be watched live on Nkarta’s website, with a replay available for four weeks.

What is Nkarta's stock symbol?

Nkarta's stock symbol is NKTX.